EDGAR Filing Documents for 0001358403-17-000087

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001358403-17-000087

Filing Date

2017-06-15

Accepted

2017-06-15 16:24:07

Documents

Effectiveness Date

2017-06-15

Reference 429

333-216656

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	s-8bellicumstockplans.htm	S-8	93976
2	EXHIBIT 5.1	exh51cooleyopinionjune2017.htm	EX-5.1	6315
3	EXHIBIT 23.1	exh231eyconsentjune2017.htm	EX-23.1	3009
4	EXHIBIT 99.1	exh991equityincentiveplan.htm	EX-99.1	198520
5		cooleylogojpegs8.jpg	GRAPHIC	9998
	Complete submission text file	0001358403-17-000087.txt		311501

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030

Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100

BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-218772 | Film No.: 17913770
SIC: 2834 Pharmaceutical Preparations